0001179110-13-014364.txt : 20130918 0001179110-13-014364.hdr.sgml : 20130918 20130918211937 ACCESSION NUMBER: 0001179110-13-014364 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130918 FILED AS OF DATE: 20130918 DATE AS OF CHANGE: 20130918 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACCELERON PHARMA INC CENTRAL INDEX KEY: 0001280600 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-9200 MAIL ADDRESS: STREET 1: 128 SYDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quisel John D CENTRAL INDEX KEY: 0001586788 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36065 FILM NUMBER: 131104556 MAIL ADDRESS: STREET 1: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 edgar.xml FORM 3 - X0206 3 2013-09-18 0 0001280600 ACCELERON PHARMA INC XLRN 0001586788 Quisel John D 128 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 VP General Counsel & Secretary Option to Purchase Common Stock 7.12 2022-12-12 Common Stock 12500 D Option to Purchase Common Stock 5.28 2022-06-07 Common Stock 25000 D Option to Purchase Common Stock 5.28 2021-12-16 Common Stock 18750 D Option to Purchase Common Stock 3.88 2020-12-02 Common Stock 62500 D Option to Purchase Common Stock 5.88 2019-12-02 Common Stock 25000 D Option to Purchase Common Stock 5.88 2018-12-17 Common Stock 12500 D Option to Purchase Common Stock 5.08 2018-03-27 Common Stock 7500 D Option to Purchase Common Stock 1.80 2017-06-12 Common Stock 2500 D Option to Purchase Common Stock 0.92 2016-11-15 Common Stock 27500 D The options of registrants common stock vest in equal quarterly installments over the first four years after the grant. The options of registrants common stock vested 25% on the first anniversary of the grant and in equal installments quarterly therafter. Exhibit List Exhibit 24 - Power of Attorney /s/ Douglas Pagan, attorney-in-fact for John D. Quisel 2013-09-18 EX-24 2 ex24quisel.htm Unassociated Document
 
 

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Kevin F. McLaughlin and Douglas W. Pagán, signing singly, as the undersigned’s true and lawful attorney-in-fact to:

 
(1)
execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Acceleron Pharma Inc. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Act”), and the rules thereunder;
     
 
(2)
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
     
 
(3)
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all the acts such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of September 12, 2013.
 

 
By:
/s/ John D. Quisel, J.D., Ph.D.
 
Name:
John D. Quisel, J.D., Ph.D.